UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Risk factors of chemotherapy‐induced nausea and vomiting: Index for personalized antiemetic prophylaxis

Cancer science, 2013-06, Vol.104 (6), p.711-717

2013

Volltextzugriff (PDF)

Atherosclerotic cardiovascular events associated with immune checkpoint inhibitors in cancer patients

Japanese journal of clinical oncology, 2022-07, Vol.52 (7), p.659-664

2022

Volltextzugriff (PDF)

Vanishing Bone Disease

Internal Medicine, 2024, pp.3271-23

2024

Volltextzugriff (PDF)

Immune checkpoint inhibitor-related myocarditis

Japanese journal of clinical oncology, 2018-01, Vol.48 (1), p.7-12

2018

Volltextzugriff (PDF)

Clonal heamatopoiesis and associated cardiovascular diseases

Japanese journal of clinical oncology, 2023-03, Vol.53 (3), p.187-194

2023

Volltextzugriff (PDF)

Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients

Japanese journal of clinical oncology, 2017-08, Vol.47 (8), p.678-682

2017

Volltextzugriff (PDF)

Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells

Molecular cell, 2019-12, Vol.76 (5), p.838-851.e5

2019

Volltextzugriff (PDF)

Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report

Japanese journal of clinical oncology, 2016-09, Vol.46 (9), p.875-878

2016

Volltextzugriff (PDF)

Early Detection and Prediction of Anthracycline-Induced Cardiotoxicity　― A Prospective Cohort Study

Circulation Journal, 2024/04/25, Vol.88(5), pp.751-759

2024

Volltextzugriff (PDF)

A Prompt Diagnosis of Superior Vena Cava Obstruction Established by Physical Examination

Internal Medicine, 2019/11/15, Vol.58(22), pp.3211-3212

Sekine, Ikuo

2019

Volltextzugriff (PDF)

Impact of Hepatitis B Surface and Core Antibody Levels on Hepatitis B Virus Reactivation

Biological and Pharmaceutical Bulletin, 2024/05/10, Vol.47(5), pp.941-945

2024

Volltextzugriff (PDF)

KIF5B-RET fusions in lung adenocarcinoma

Nature medicine, 2012-03, Vol.18 (3), p.375-377

2012

Volltextzugriff (PDF)

Cardiovascular toxic effects of targeted cancer therapy

Japanese journal of clinical oncology, 2017-09, Vol.47 (9), p.779-785

2017

Volltextzugriff (PDF)

A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patients

Cancer science, 2020-05, Vol.111 (5), p.1685-1691

2020

Volltextzugriff (PDF)

Comprehensive histologic analysis of ALK-rearranged lung carcinomas

The American journal of surgical pathology, 2011-08, Vol.35 (8), p.1226-1234

2011

Volltextzugriff (PDF)

GL2-5 Criteria for treatment efficacy, analgesics, RI therapy, rehabilitation, and nursing

Annals of oncology, 2022-07, Vol.33, p.S460

Sekine, Ikuo

2022

Volltextzugriff (PDF)

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

The lancet oncology, 2009-02, Vol.10 (2), p.115-124

2009

Volltextzugriff (PDF)

c-MET/Phospho-MET Protein Expression and MET Gene Copy Number in Non-small Cell Lung Carcinomas

Journal of thoracic oncology, 2012-02, Vol.7 (2), p.331-339

2012

Volltextzugriff (PDF)

Clinical development of immune checkpoint inhibitors in Japan—the same goal, different paths

Japanese journal of clinical oncology, 2023-10, Vol.53 (10), p.873-874

Sekine, Ikuo

2023

Volltextzugriff (PDF)

Severe hepatitis arising from ipilimumab administration, following melanoma treatment with nivolumab

Japanese journal of clinical oncology, 2017-02, Vol.47 (2), p.175-178

2017

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2005-10, Vol.23 (28), p.6829-6837

2005

Volltextzugriff (PDF)

Cardiology consultation in oncology practice: a 5-year survey

Japanese journal of clinical oncology, 2020-12, Vol.50 (12), p.1419-1425

2020

Volltextzugriff (PDF)

EGFR Mutations Predict Survival Benefit From Gefitinib in Patients With Advanced Lung Adenocarcinoma: A Historical Comparison of Patients Treated Before and After Gefitinib Approval in Japan

Journal of clinical oncology, 2008-12, Vol.26 (34), p.5589-5595

2008

Volltextzugriff (PDF)

Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study

Journal of cachexia, sarcopenia and muscle, 2023-06, Vol.14 (3), p.1274-1285

2023

Volltextzugriff (PDF)

Efficacy of platinum agents for stage III non-small-cell lung cancer following platinum-based chemoradiotherapy: a retrospective study

BMC cancer, 2022-03, Vol.22 (1), p.342-342, Article 342

2022

Volltextzugriff (PDF)

1 – 25 von 353

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(311)
Mit Volltextzugriff
(324)

Publikationsform

Sprache

Englisch
(336)
Japanisch
(21)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(234)
Life Sciences & Biomedicine
(220)
Humans
(191)
Oncology
(158)
Male
(129)
Female
(127)
Aged
(112)
Middle Aged
(108)
Adult
(97)
Lung Neoplasms - Drug Therapy
(75)
Chemotherapy
(64)
Lung Cancer
(56)
Biological And Medical Sciences
(54)
Medical Sciences
(52)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(47)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(44)
Lung Neoplasms - Pathology
(43)
Tumors
(40)
Pneumology
(38)
Tumors Of The Respiratory System And Mediastinum
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Japanese Journal Of Clinical Oncology
(44)
Journal Of Thoracic Oncology
(21)
Cancer Science
(16)
Lung Cancer
(15)
Journal Of Clinical Oncology
(14)
Internal Medicine
(11)
Free Radical Biology & Medicine
(8)
Clinical Lung Cancer
(6)
Annals Of Oncology
(5)
Bmc Cancer
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Risk factors of chemotherapy‐induced nausea and vomiting: Index for personalized antiemetic prophylaxis

Atherosclerotic cardiovascular events associated with immune checkpoint inhibitors in cancer patients

Vanishing Bone Disease

Immune checkpoint inhibitor-related myocarditis

Clonal heamatopoiesis and associated cardiovascular diseases

Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients

Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells

Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report

Early Detection and Prediction of Anthracycline-Induced Cardiotoxicity　― A Prospective Cohort Study

A Prompt Diagnosis of Superior Vena Cava Obstruction Established by Physical Examination

Impact of Hepatitis B Surface and Core Antibody Levels on Hepatitis B Virus Reactivation

KIF5B-RET fusions in lung adenocarcinoma

Cardiovascular toxic effects of targeted cancer therapy

A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patients

Comprehensive histologic analysis of ALK-rearranged lung carcinomas

GL2-5 Criteria for treatment efficacy, analgesics, RI therapy, rehabilitation, and nursing

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

c-MET/Phospho-MET Protein Expression and MET Gene Copy Number in Non-small Cell Lung Carcinomas

Clinical development of immune checkpoint inhibitors in Japan—the same goal, different paths

Severe hepatitis arising from ipilimumab administration, following melanoma treatment with nivolumab

Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non–Small-Cell Lung Cancer

Cardiology consultation in oncology practice: a 5-year survey

EGFR Mutations Predict Survival Benefit From Gefitinib in Patients With Advanced Lung Adenocarcinoma: A Historical Comparison of Patients Treated Before and After Gefitinib Approval in Japan

Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study

Efficacy of platinum agents for stage III non-small-cell lung cancer following platinum-based chemoradiotherapy: a retrospective study

Suchergebnisse filtern